Human Amniotic Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human Amniotic Mesenchymal Stem Cells, covering 2025-08-11 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency [Phase 1, Phase 2]